SembioSys Genetics, Inc

Safflower In safflower plants expressing biopharmaceuticals, the protein of interest is fused to oleosin, the protein that forms oil bodies within the safflower seeds. The seeds can be crushed and the oil bodies then easily purified by centrifugation. This oleosin-fusion protein system was first developed by SemBioSys Genetics, Inc., in safflower or oilseed rape. 

SembioSys Genetics, Inc. Calgary, Alberta Insulin, ApoAI Safflower seeds... 

SemBioSys Genetics Inc. (Calgary, Canada), in addition to insulin and apoHpopro-tein AI, demonstrated a proof-of-concept for proteins addressing osteoporosis, pulmonary and Hver fibrosis, psoriasis and gastrointestinal disorders. Plantigen Inc. (London, Canada) has proof of principle for several products under development Those include glutamic acid decarboxylase (GAD) for the treatment of type 1 diabetes interleukin-10 (IL-10) for treatment of inflammatory bowel disease interleukin-4 (IL-4) for use as adjuvant to enhance immune response and major histocompati-ble complex (MHG) and cytokines for use in organ transplants. 

SEMBIOSYS GENETICS INC, CA GUTH JACOB, US BOOTH JOSEPH, CA BEAZER MITCH, CA SHAFER KENT, CA... 

MARTEK BIOSCIENCES CORP, US SEMBIOSYS GENETICS INC, CA METZ JAMES G, US KUNER JERRY M, US LIPPMEIER JAMES CASEY, US MOLONEY MAURICE MARTIN, CA NYKIFORUK CORY LEE, CA... 

---